HomeVICO • STO
add
Vicore Pharma Holding AB
Previous close
kr 9.82
Day range
kr 9.75 - kr 9.97
Year range
kr 6.09 - kr 14.10
Market cap
2.74B SEK
Avg Volume
497.74K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 760.00K | — |
Operating expense | 116.81M | 93.57% |
Net income | -113.47M | -89.29% |
Net profit margin | -14.93K | — |
Earnings per share | -0.48 | 11.11% |
EBITDA | -115.49M | -93.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 835.84M | 119.71% |
Total assets | 866.72M | 113.01% |
Total liabilities | 68.07M | 133.39% |
Total equity | 798.66M | — |
Shares outstanding | 234.61M | — |
Price to book | 2.89 | — |
Return on assets | -31.48% | — |
Return on capital | -33.99% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -113.47M | -89.29% |
Cash from operations | -100.39M | -15.00% |
Cash from investing | 219.69M | 220.21% |
Cash from financing | — | — |
Net change in cash | 118.45M | 637.71% |
Free cash flow | -72.79M | -13.55% |
About
Founded
2000
Website
Employees
36
